The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Leveraging personalized circulating tumor DNA (ctDNA) for detection and monitoring of molecular residual disease in high-risk melanoma.
 
Sofia Genta
No Relationships to Disclose
 
Daniel Vilarim Araujo
Honoraria - MSD; Pfizer
Consulting or Advisory Role - MSD Oncology; MSD Oncology
Travel, Accommodations, Expenses - Pfizer
 
Sareh Keshavarzi
No Relationships to Disclose
 
Thiago Pimentel Muniz
No Relationships to Disclose
 
Zaid Saeed Kamil
No Relationships to Disclose
 
Karen Howarth
Employment - Inivata
Stock and Other Ownership Interests - Inivata; NeoGenomics Laboratories
Research Funding - Inivata
Patents, Royalties, Other Intellectual Property - Patent pending
 
Samantha Terrell
No Relationships to Disclose
 
Andy Joad
No Relationships to Disclose
 
Robert Ventura
Employment - Epivax Oncology; Inivata
 
Andrea Covelli
No Relationships to Disclose
 
Samuel Saibil
Consulting or Advisory Role - Immunocore; Janssen; Novartis; Sanofi
Travel, Accommodations, Expenses - Iovance Biotherapeutics
 
Pavlina Spiliopoulou
No Relationships to Disclose
 
Olga Vornicova
Consulting or Advisory Role - Merck Serono; Novartis
Speakers' Bureau - BMS; Medison; MSD Oncology; Novartis
 
Alexandra Maria Easson
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Patents, Royalties, Other Intellectual Property - University Health Network
 
Marcus O. Butler
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Adaptimmune; Adaptimmune; Bristol-Myers Squibb; EMD Serono; Genzyme; GlaxoSmithKline; GlaxoSmithKline; Immunocore; Immunovaccine; Instil Bio; Iovance Biotherapeutics; LaRoche Posay; Medison; Merck; Novartis; Pfizer; Sanofi; Sun Pharma
Research Funding - Merck; Takara Bio
Expert Testimony - Merck
 
Lillian L. Siu
Leadership - Treadwell Therapeutics (I)
Stock and Other Ownership Interests - Agios (I)
Consulting or Advisory Role - Amgen; Arvinas; AstraZeneca/MedImmune; Daiichi Sankyo/UCB Japan; GlaxoSmithKline; Hookipa Pharma; InterRNA; Janpix; Janssen; Merck; Navire; Oncorus; Relay Therapeutics; Roche; Sanofi; Seagen; Tessa Therapeutics; Voronoi Health Analytics
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVID Radiopharmaceuticals (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Intensity Therapeutics (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Shattuck Labs (Inst); Symphogen (Inst)
 
Scott Victor Bratman
Employment - Adela
Leadership - Adela
Stock and Other Ownership Interests - Adela
Research Funding - Nektar
Patents, Royalties, Other Intellectual Property - Co-inventor and holder of a patent related to circulating tumor DNA detection technology.; Co-inventor of patents related to cell-free DNA methylation analysis technology. (Inst)
 
Anna Spreafico
Honoraria - Bristol-Myers Squibb; Medison & Immunocore
Consulting or Advisory Role - Bristol-Myers Squibb; Medison & Immunocore; Merck; Novartis; Oncorus
Research Funding - Alkermes; Amgen (Inst); Array BioPharma; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck; Northern Biologics; Novartis; Replimune; Roche; Surface Oncology; Symphogen; Treadwell Therapeutics (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Idera; Janssen Oncology; Merck; Roche